An unconfirmed rumor about a possible Spectrum Pharmaceuticals (SPPI) buyout was reported by TheFlyontheWall during Friday's session. This rumor also supports the ongoing speculation that SPPI could be acquired by a larger specialty drug maker following two drug reviews scheduled this fall.
September 7: Zevalin
October 8: Fusilev
After a brief pullback last week, shares of SPPI are likely to continue their advance heading into the coming week.
Reni J. Benjamin, Rodman and Renshaw biotech analyst, told Jonathan Moreland of RealMoney, “Company's like Bayer or Bristol-Myers (BMY) may also look at the company more seriously if they are able to successfully market Zevalin.”
SPPI announced that it acquired 100% of the rights to RenaZorb® which is currently being studied in trials for hyperphosphatemia in patients with chronic kidney disease.
SPPI is scheduled to report Q2 earnings via webcast on August 13, 2009 at 12:00 PM ET. Interested investors can access the webcast here.
CONCLUSION
SPPI’s move to acquire all rights to RenaZorb® indicates to me that Allergan (AGN), who has been working to establish its urological drug division, may now be interested in bidding on SPPI.
While this is merely speculation on my part, the possibilities certainly appear to be growing, rather than shrinking, along with SPPI’s share price.
Keep your eye on SPPI.
Disclosure: Long SPPI.
To receive Justin M. Hall’s articles by email:
Register for a free account at SeekingAlpha by clicking “Login” at the bar on the bottom of this page.
Under Justin’s photo, click “Follow.”
Edit your “Profile” to receive “Stock Alerts and Author Alerts” by email.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha
community. Instablog posts are not selected, edited or screened by Seeking Alpha editors,
in contrast to contributors' articles.
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
Spectrum Pharmaceuticals: Rumor of Buyout Talks, Speculation Persists 0 comments
To receive Justin M. Hall’s articles by email:
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
Latest Followers
Posts by Ticker
Latest Comments
Most Commented
Posts by Themes